Amarin Corporation: Commercializing Vascepa, the first and only pure EPA omega-3 fatty acid approved to lower triglyceride levels in adults. Presented (+) data from REDUCE-IT CV Outcomes trial at AHA. FY19 revenue of $429.8M and FY20 revenue guidance of $650M-$700M.
Based in...
US - Middle Atlantic
Clinical Stage
Disease Space
Biotechnology, Pharmaceuticals
Public, USA
Market Cap
1B +
Therapeutic Modalities
Small Molecule
1430 Route 206
Suite 200
Bedminster, NJ 07921
United States

Top 10 Holders of Amarin Corporation Plc Sponsored ADR

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Baker Bros. Advisors LP 9.77 34,496,685 143.85 13F 6/30/20
Artisan Partners Holdings LP 4.63 16,351,613 68.19 13F 6/30/20
T. Rowe Price Associates, Inc. (Investment Management) 3.17 11,184,323 46.64 13F 6/30/20
Artisan Partners LP 2.48 8,819,880 36.78 Funds 6/30/20
Boxer Capital LLC 1.98 7,000,000 29.19 13F 6/30/20
D.E. Shaw & Co., Inc. 1.61 5,698,563 23.76 13F 6/30/20
Federated Global Investment Management Corp. 1.50 5,300,300 22.10 13F 6/30/20
Sofinnova Ventures, Inc. 1.48 5,208,305 21.72 13F 6/30/20
Eversept Partners LP 1.36 4,786,101 19.96 13F 6/30/20
Rock Springs Capital Management LP 1.32 4,650,000 19.39 13F 6/30/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.